Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2005 Jan;76(1):76–81. doi: 10.1136/jnnp.2004.041491

Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke

A Di 1, M Fiorelli 1, D Toni 1, M Sacchetti 1, S Lorenzano 1, A Falcou 1, M Ciarla 1, M Suppa 1, L Bonanni 1, G Bertazzoni 1, F Aguglia 1, C Argentino 1
PMCID: PMC1739298  PMID: 15607999

Abstract

Objectives: Successful prediction of cardiac complications early in the course of acute ischaemic stroke could have an impact on the clinical management. Markers of myocardial injury on admission deserve investigation as potential predictors of poor outcome from stroke.

Methods: We prospectively investigated 330 consecutive patients with acute ischaemic stroke admitted to our emergency department based stroke unit. We analysed the association of baseline levels of cardiac troponin I (cTnI) with (a) all-cause mortality over a six month follow up, and (b) inhospital death or major non-fatal cardiac event (angina, myocardial infarction, or heart failure).

Results: cTnI levels on admission were normal (lower than 0.10 ng/ml) in 277 patients (83.9%), low positive (0.10–0.39 ng/ml) in 35 (10.6%), and high positive (0.40 ng/ml or higher) in 18 (5.5%). Six month survival decreased significantly across the three groups (p<0.0001, log rank test for trend). On multivariate analysis, cTnI level was an independent predictor of mortality (low positive cTnI, hazard ratio (HR) 2.14; 95% CI 1.13 to 4.05; p = 0.01; and high positive cTnI, HR 2.47; 95% CI 1.22 to 5.02; p = 0.01), together with age and stroke severity. cTnI also predicted a higher risk of the combined endpoint "inhospital death or non-fatal cardiac event". Neither the adjustment for other potential confounders nor the adjustment for ECG changes and levels of CK-MB and myoglobin on admission altered these results.

Conclusions: cTnI positivity on admission is an independent prognostic predictor in acute ischaemic stroke. Whether further evaluation and treatment of cTnI positive patients can reduce cardiac morbidity and mortality should be the focus of future research.

Full Text

The Full Text of this article is available as a PDF (97.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams H. P., Jr, Bendixen B. H., Kappelle L. J., Biller J., Love B. B., Gordon D. L., Marsh E. E., 3rd Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 Jan;24(1):35–41. doi: 10.1161/01.str.24.1.35. [DOI] [PubMed] [Google Scholar]
  2. Adams J. E., 3rd, Bodor G. S., Dávila-Román V. G., Delmez J. A., Apple F. S., Ladenson J. H., Jaffe A. S. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation. 1993 Jul;88(1):101–106. doi: 10.1161/01.cir.88.1.101. [DOI] [PubMed] [Google Scholar]
  3. Adams J. E., 3rd, Schechtman K. B., Landt Y., Ladenson J. H., Jaffe A. S. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem. 1994 Jul;40(7 Pt 1):1291–1295. [PubMed] [Google Scholar]
  4. Beamer N. B., Coull B. M., Clark W. M., Briley D. P., Wynn M., Sexton G. Persistent inflammatory response in stroke survivors. Neurology. 1998 Jun;50(6):1722–1728. doi: 10.1212/wnl.50.6.1722. [DOI] [PubMed] [Google Scholar]
  5. Bounds J. V., Wiebers D. O., Whisnant J. P., Okazaki H. Mechanisms and timing of deaths from cerebral infarction. Stroke. 1981 Jul-Aug;12(4):474–477. doi: 10.1161/01.str.12.4.474. [DOI] [PubMed] [Google Scholar]
  6. Brott T., Adams H. P., Jr, Olinger C. P., Marler J. R., Barsan W. G., Biller J., Spilker J., Holleran R., Eberle R., Hertzberg V. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989 Jul;20(7):864–870. doi: 10.1161/01.str.20.7.864. [DOI] [PubMed] [Google Scholar]
  7. Bruno A., Biller J., Adams H. P., Jr, Clarke W. R., Woolson R. F., Williams L. S., Hansen M. D. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology. 1999 Jan 15;52(2):280–284. doi: 10.1212/wnl.52.2.280. [DOI] [PubMed] [Google Scholar]
  8. Cannon C. P., Battler A., Brindis R. G., Cox J. L., Ellis S. G., Every N. R., Flaherty J. T., Harrington R. A., Krumholz H. M., Simoons M. L. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001 Dec;38(7):2114–2130. doi: 10.1016/s0735-1097(01)01702-8. [DOI] [PubMed] [Google Scholar]
  9. Dixit S., Castle M., Velu R. P., Swisher L., Hodge C., Jaffe A. S. Cardiac involvement in patients with acute neurologic disease: confirmation with cardiac troponin I. Arch Intern Med. 2000 Nov 13;160(20):3153–3158. doi: 10.1001/archinte.160.20.3153. [DOI] [PubMed] [Google Scholar]
  10. Hartmann A., Rundek T., Mast H., Paik M. C., Boden-Albala B., Mohr J. P., Sacco R. L. Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology. 2001 Dec 11;57(11):2000–2005. doi: 10.1212/wnl.57.11.2000. [DOI] [PubMed] [Google Scholar]
  11. James P., Ellis C. J., Whitlock R. M., McNeil A. R., Henley J., Anderson N. E. Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. BMJ. 2000 Jun 3;320(7248):1502–1504. doi: 10.1136/bmj.320.7248.1502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johnston K. C., Li J. Y., Lyden P. D., Hanson S. K., Feasby T. E., Adams R. J., Faught R. E., Jr, Haley E. C., Jr Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke. 1998 Feb;29(2):447–453. doi: 10.1161/01.str.29.2.447. [DOI] [PubMed] [Google Scholar]
  13. Kasner S. E., Demchuk A. M., Berrouschot J., Schmutzhard E., Harms L., Verro P., Chalela J. A., Abbur R., McGrade H., Christou I. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke. 2001 Sep;32(9):2117–2123. doi: 10.1161/hs0901.095719. [DOI] [PubMed] [Google Scholar]
  14. Kolin A., Norris J. W. Myocardial damage from acute cerebral lesions. Stroke. 1984 Nov-Dec;15(6):990–993. doi: 10.1161/01.str.15.6.990. [DOI] [PubMed] [Google Scholar]
  15. Morrow D. A., Cannon C. P., Rifai N., Frey M. J., Vicari R., Lakkis N., Robertson D. H., Hille D. A., DeLucca P. T., DiBattiste P. M. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA. 2001 Nov 21;286(19):2405–2412. doi: 10.1001/jama.286.19.2405. [DOI] [PubMed] [Google Scholar]
  16. Morrow D. A., Rifai N., Tanasijevic M. J., Wybenga D. R., de Lemos J. A., Antman E. M. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy. Clin Chem. 2000 Apr;46(4):453–460. [PubMed] [Google Scholar]
  17. Norris J. W., Hachinski V. C., Myers M. G., Callow J., Wong T., Moore R. W. Serum cardiac enzymes in stroke. Stroke. 1979 Sep-Oct;10(5):548–553. doi: 10.1161/01.str.10.5.548. [DOI] [PubMed] [Google Scholar]
  18. Oppenheimer S. The insular cortex and the pathophysiology of stroke-induced cardiac changes. Can J Neurol Sci. 1992 May;19(2):208–211. [PubMed] [Google Scholar]
  19. Silver F. L., Norris J. W., Lewis A. J., Hachinski V. C. Early mortality following stroke: a prospective review. Stroke. 1984 May-Jun;15(3):492–496. doi: 10.1161/01.str.15.3.492. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES